Prevalence and Subjective Impairment of Quality of Life (QoL) Due to Dermatologic Diseases in Internal Medicine Patients
|ClinicalTrials.gov Identifier: NCT01044043|
Recruitment Status : Completed
First Posted : January 7, 2010
Last Update Posted : January 11, 2011
This is a 3 months single centre clinical patient-oriented study to evaluate the prevalence and impairment in QOL of dermatologic diseases in patients hospitalised in internal medicine.
Up to 200 patients hospitalised at the division of internal medicine for any reason are going to be offered participation by a patient information form given to patients at the time of admission, as well as oral information about the study. Written informed consent will be obtained by the investigators after patients have had adequate time to consider their participation in the study.
Participating patients will be examined clinically for dermatologic pathologies at a single visit. In the case of signs of dermatologic disease, investigators are going to recommend further diagnostic procedures to the physician in charge and/or the referring physician, depending on the urgency of the suspected diagnosis. This procedure is meant to avoid giving referring physicians the impression that active patient acquisition for the department of Dermatology is an aim of this study. Diagnostic procedures that are performed upon suspicion of a specific dermatologic disease at the Division of Internal Medicine are going to be performed during the hospitalisation period. All other diagnostic or operative procedures are going to be advised to the referring physician.
Study participants are going to be interviewed by the investigators about impairment in QOL of their illnesses. Two separate questionnaires are going to be filled in by each participant. For measurement of general QOL, the widely used SF-12 questionnaire (8 questions) is going to be used. To measure specific impairment in QOL by dermatologic disease, participants are going to be asked to fill in the DLQI (Dermatology life quality index, 10 questions). Photographic documentation of specific identified lesions will be made and pictures stored exclusively in the secured electronic patient file (KISIM). Medication and all identified diseases will be noted. All diagnostically useful information is going to be recorded in the patient file and transmitted to the referring physician in the discharge letter.
|Condition or disease||Intervention/treatment|
|Dermatologic Disease of Inpatients in Internal Medicine||Procedure: clinical examination and quality of life questionnaire|
|Study Type :||Observational|
|Estimated Enrollment :||200 participants|
|Study Start Date :||November 2009|
|Actual Primary Completion Date :||January 2010|
|Actual Study Completion Date :||December 2010|
Procedure: clinical examination and quality of life questionnaire
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT01044043
|Study Director:||01 Studienregister MasterAdmins||UniversitaetsSpital Zuerich|